Panacea Biotec Limited (PANACEABIO.NS)

INR 463.0

(1.47%)

Inventory Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual inventory in 2023 was 1.77 Billion INR , down -11.95% from previous year.
Panacea Biotec Limited's latest quarterly inventory in 2024 Q1 was - INR , down -100.0% from previous quarter.
Panacea Biotec Limited reported annual inventory of 2.02 Billion INR in 2022, down -5.0% from previous year.
Panacea Biotec Limited reported annual inventory of 2.12 Billion INR in 2021, up 22.16% from previous year.
Panacea Biotec Limited reported quarterly inventory of 1.99 Billion INR for 2023 Q2, down 0.0% from previous quarter.
Panacea Biotec Limited reported quarterly inventory of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Inventory Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Inventory of Panacea Biotec Limited (2023 - 2004)

Year	Inventory	Inventory Growth
2023	1.77 Billion INR	-11.95%
2022	2.02 Billion INR	-5.0%
2021	2.12 Billion INR	22.16%
2020	1.74 Billion INR	17.91%
2019	1.47 Billion INR	81.38%
2018	814.27 Million INR	-75.64%
2017	3.34 Billion INR	8.59%
2016	3.07 Billion INR	0.83%
2015	3.05 Billion INR	-1.61%
2014	3.1 Billion INR	41.13%
2013	2.19 Billion INR	-17.96%
2012	2.67 Billion INR	-30.45%
2011	3.85 Billion INR	-6.18%
2010	4.1 Billion INR	-10.28%
2009	4.57 Billion INR	1.41%
2008	4.51 Billion INR	110.32%
2007	2.14 Billion INR	2.57%
2006	2.09 Billion INR	15.12%
2005	1.81 Billion INR	-6.02%
2004	1.93 Billion INR	0.0%

Year	Inventory	Inventory Growth
2024 Q1	- INR	-100.0%
2023 Q2	1.99 Billion INR	0.0%
2023 Q1	- INR	-100.0%
2023 FY	1.77 Billion INR	-11.95%
2023 Q4	1.77 Billion INR	0.0%
2023 Q3	- INR	-100.0%
2022 FY	2.02 Billion INR	-5.0%
2022 Q1	- INR	-100.0%
2022 Q2	1.94 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q4	2.02 Billion INR	0.0%
2021 Q4	2.12 Billion INR	0.0%
2021 Q2	2.07 Billion INR	0.0%
2021 FY	2.12 Billion INR	22.16%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2020 FY	1.74 Billion INR	17.91%
2020 Q2	1.52 Billion INR	0.0%
2020 Q4	1.74 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2019 Q4	1.47 Billion INR	0.0%
2019 Q3	- INR	-100.0%
2019 Q2	1.08 Billion INR	0.0%
2019 Q1	- INR	-100.0%
2019 FY	1.47 Billion INR	81.38%
2018 Q4	814.27 Million INR	0.0%
2018 FY	814.27 Million INR	-75.64%
2017 FY	3.34 Billion INR	8.59%
2016 FY	3.07 Billion INR	0.83%
2015 FY	3.05 Billion INR	-1.61%
2014 FY	3.1 Billion INR	41.13%
2013 FY	2.19 Billion INR	-17.96%
2012 FY	2.67 Billion INR	-30.45%
2011 FY	3.85 Billion INR	-6.18%
2010 FY	4.1 Billion INR	-10.28%
2009 FY	4.57 Billion INR	1.41%
2008 FY	4.51 Billion INR	110.32%
2007 FY	2.14 Billion INR	2.57%
2006 FY	2.09 Billion INR	15.12%
2005 FY	1.81 Billion INR	-6.02%
2004 FY	1.93 Billion INR	0.0%

Peer Inventory Comparison of Panacea Biotec Limited

Name	Inventory	Inventory Difference
Biocon Limited	49.43 Billion INR	96.401%
Blue Jet Healthcare Limited	1.29 Billion INR	-37.051%
Concord Biotech Limited	2.07 Billion INR	14.433%
Dishman Carbogen Amcis Limited	8.82 Billion INR	79.846%
Jubilant Ingrevia Limited	9.41 Billion INR	81.096%
Lyka Labs Limited	95.71 Million INR	-1759.002%
Piramal Pharma Limited	21.75 Billion INR	91.822%
SMS Lifesciences India Limited	812.1 Million INR	-119.11%
Supriya Lifescience Limited	852.49 Million INR	-108.73%
Syngene International Limited	2.38 Billion INR	25.392%
TAKE Solutions Limited	7.96 Million INR	-22254.271%
Zota Health Care Limited	537.66 Million INR	-230.952%